Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
about
The role of suppressors of cytokine signalling in human neoplasmsCullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.Favorable prognostic value of SOCS2 and IGF-I in breast cancer.Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activationPhysical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer.Differential Expression of Ccn4 and Other Genes Between Metastatic and Non-metastatic EL4 Mouse Lymphoma Cells.Genetics of breast cancer bone metastasis: a sequential multistep pattern.SOCS proteins in regulation of receptor tyrosine kinase signaling.Cell regulation by phosphotyrosine-targeted ubiquitin ligases.MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer.Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.
P2860
Q27026783-8E5D17C3-321C-4559-8EEA-17B18AF8B4B9Q30577461-3FCE60F3-E2FC-472F-92E7-48559AA52705Q33291671-8A8F3843-D833-481C-AF1B-967CBA018947Q33569316-397EAA0A-4E98-45BC-89B2-4B2C23E0AE6EQ33810288-76532ECD-7FBE-4A33-8223-30ABAEAA439FQ33816368-780AC10D-0879-4EF0-9B81-E3C819F4DEFDQ33916825-5F0C437D-9328-42F1-9C19-6ED9997B4DEFQ34051993-D8FCDFEF-56F5-490C-9CBC-44480F0519ABQ37569984-97D46F17-25E7-41FC-B3A1-F2547E2456C5Q38184928-2820894B-251D-4A95-BD50-F5B47CDE3B15Q38202542-0EE03A5A-3C78-4AF7-B022-0CA59CD2E091Q38380126-8D31D561-609D-440F-BFDD-510AD3CCB0B0Q39173393-F3F75386-0D1C-4A22-88AB-50966667E675Q39869306-E83FA3E6-C771-42C6-8971-74628D7DFDDEQ52721250-0AFCFF54-0607-4F08-8EF5-3D9AB8CE1D29Q54269263-72A9F2EF-2143-481D-B628-18570ECD9EBB
P2860
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
@ast
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
@en
type
label
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
@ast
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
@en
prefLabel
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
@ast
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
@en
P2093
P2860
P356
P1476
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
@en
P2093
F Farabegoli
M Taffurelli
P2860
P304
P356
10.1136/JCP.2004.024919
P407
P577
2005-10-01T00:00:00Z